Novavax Inc. Stock Outperforms Market On Strong Trading Day

Verizon Communications Inc

Change company Symbol lookup

Select an option...

VZ Verizon Communications Inc

CETX Cemtrex Inc

RNXT RenovoRx Inc

BNTX BioNTech SE

ARTW Art's Way Manufacturing Co Inc

ARIZU Arisz Acquisition Corp

OSH Oak Street Health Inc

LESL Leslie's Inc

AAPL Apple Inc

BYM BlackRock Municipal Income Quality Trust

Communication Services : Diversified Telecommunication Services | Large Cap Value

Company profile

Verizon Communications Inc. is a holding company. The Company, through its subsidiaries, provides communications, information and entertainment products and services to consumers, businesses, and governmental agencies. Its reportable segments are Verizon Consumer Group and Verizon Business Group. Its Consumer segment provides wireless and wireline communications services. Its wireless services are provided across wireless networks in the United States (U.S.) under the Verizon brand. Its wireline services are provided in nine states in the Mid-Atlantic and Northeastern U.S., as well as Washington D.C., over its fiber-optic network under the Fios brand and over a traditional copper-based network. Its Business segment provides wireless and wireline communications services and products, including data, video and conferencing services, security and managed network services, local and long-distance voice services and network access to deliver various Internet of Things services and products.

Novavax Inc. Stock Outperforms Market On Strong Trading Day

5:15 pm ET February 2, 2023 (MarketWatch) Print

This article was automatically generated by MarketWatch using technology from Automated Insights.

Shares of Novavax Inc. (NVAX) advanced 6.95% to $12.01 Thursday, on what proved to be an all-around mixed trading session for the stock market, with the NASDAQ Composite Index rising 3.25% to 12,200.82 and the Dow Jones Industrial Average falling 0.11% to 34,053.94. This was the stock's third consecutive day of gains. Novavax Inc. closed $89.38 below its 52-week high ($101.39), which the company achieved on February 7th.

The stock outperformed some of its competitors Thursday, as Johnson & Johnson (JNJ) rose 0.38% to $165.54, Pfizer Inc. (PFE) rose 0.84% to $44.34, and Merck & Co. Inc. (MRK) fell 3.29% to $103.46. Trading volume (9.7 M) eclipsed its 50-day average volume of 7.4 M.

Data source: Dow Jones Market Data, FactSet. Data compiled February 2, 2023.

(END) Dow Jones Newswires

February 02, 2023 17:15 ET (22:15 GMT)

Premarket

Change Since Close

Market Hours

Novavax Inc. Stock Outperforms Market On Strong Trading Day